Allergen immunotherapy in atopic dermatitis: Light and shadow in children

被引：14

作者：

Caminiti, Lucia ^{[1
]}

Panasiti, Ilenia ^{[1
]}

Landi, Massimo ^{[2
]}

De Filippo, Maria ^{[3
]}

Olcese, Roberta ^{[4
]}

Ciprandi, Giorgio ^{[5
]}

Vernich, Mario ^{[6
]}

Carelli, Francesco ^{[7
]}

Votto, Martina ^{[3
]}

Barberi, Salvatore ^{[6
]}

机构：

[1] Univ Messina, Allergy Unit, Dept Paediat, Messina, Italy

[2] Inst Biomed Res & Innovat IRIB, Paediat Natl Healthcare Syst Turin, Turin, Italy

[3] Univ Pavia, Fdn IRCSS Policlin San Matteo, Paediat Clin, Dept Paediat, Pavia, Italy

[4] Ist Giannina Gaslini, Allergy Ctr, Genoa, Italy

[5] Casa Cura Villa Montallegro, Allergy Clin, Genoa, Italy

[6] RHO, ASST Rhodense, Paediat Unit, Milan, Italy

[7] Policlin Giovanni XXIII, Azienza Osped Univ, Paediat Unit, Bari, Italy

来源：

PEDIATRIC ALLERGY AND IMMUNOLOGY | 2020年 / 31卷

关键词：

allergic immunotherapy; Atopic dermatitis; children; GUIDELINES; ECZEMA;

D O I：

10.1111/pai.13390

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Atopic dermatitis (AD) is a chronic remitting-relapsing inflammatory skin disorder. Due to the multifactorial pathogenesis, there are numerous therapeutic management approaches, mainly based on symptomatic treatments. In recent years, allergen immunotherapy (AIT) has been progressively advanced as targeted disease-modifying treatment of allergic disease. The most recent guideline from the American Academy of Dermatology concludes that data available do not support its use in AD. The Joint Task Force and The European Academy of Dermatology suggest that clinicians can consider AIT treatment in selected patients characterized by aeroallergen sensitization, prevalently HDM, severe AD, and clinical exacerbation after exposure to the causative allergen. Nevertheless, its role in AD is still under debate, especially in children.

引用

页码：46 / 48

页数：3

共 50 条

[31] The potential role of allergen-specific sublingual immunotherapy in atopic dermatitis
Mastrandrea, F
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2004, 5 (05) : 281 - 294
[32] Treatment of Severe Atopic Dermatitis with a Combination of Subcutaneous Allergen Immunotherapy and Cyclosporin
Nahm, Dong-Ho
Kim, Myoung-Eun
YONSEI MEDICAL JOURNAL, 2012, 53 (01) : 158 - 163
[33] Treatment of severe atopic dermatitis with a combination of subcutaneous allergen immunotherapy and cyclosporin
Nahm, D.
Kim, M.
ALLERGY, 2012, 67 : 181 - 181
[34] Combined application of dupilumab and mite allergen-specific immunotherapy in children with moderate to severe atopic dermatitis
Ding, Bo
Lai, Yin
Lu, Yanming
ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2023, 51 (02) : 184 - 190
[35] Immunotherapy rationale in children with exacerbation of moderate atopic dermatitis
Slavyanskaya, T. A.
Derkach, V. V.
ALLERGY, 2013, 68 : 161 - 161
[36] Rationale for the use of multiagent immunotherapy in children with atopic dermatitis
Slavyanskaya, T.
Derkach, V
ALLERGY, 2014, 69 : 190 - 190
[37] Comparative characteristic of effectiveness of immunotherapy of children with atopic dermatitis
Derkach, V. V.
Slavyanskaya, T. A.
ALLERGY, ASTHMA & IMMUNOPHYSIOLOGY: RECENT ADVANCES IN UNDERSTANDING AND MANAGEMENT, 2015, : 45 - 49
[38] Combined immunotherapy in children with atopic dermatitis: rationale for application
Derkach, V. V.
Slavyanskaya, T. A.
ALLERGY, ASTHMA & IMMUNOPHYSIOLOGY: FROM GENES TO CLINICAL MANAGEMENT, 2014, : 63 - 67
[39] Allergen sensitisation and other allergic diseases in children with atopic dermatitis
Yilmaz, M.
Dogruel, D.
Inal, A.
Karakoc, G.
Altintas, D.
Kendirli, S.
ALLERGY, 2009, 64 : 276 - 276
[40] Immunotherapy in atopic dermatitis
Mastrandrea, F
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (01) : 49 - 63

← 1 2 3 4 5 →